礼来(LLY)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LLY 礼来

已收盘 05-07 16:00:00 EDT

777.77

+11.09

+1.45%

盘后777.26

-0.51-0.07%

19:59 EDT

最高779.09	最低762.11	成交量287.94万
今开768.90	昨收766.68	日振幅2.21%
总市值7,395亿	流通市值7,373亿	总股本9.51亿
成交额22.29亿	换手率0.30%	流通股本9.48亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"LLY","market":"US","secType":"STK","nameCN":"礼来","latestPrice":777.77,"timestamp":1715112000000,"preClose":766.68,"halted":0,"volume":2879447,"hourTrading":{"tag":"盘后","latestPrice":777.26,"preClose":777.77,"latestTime":"19:59 EDT","volume":187635,"amount":145909315.1593,"timestamp":1715126353101},"delay":0,"floatShares":948000000,"shares":950766100,"eps":5.8,"marketStatus":"已收盘","marketStatusCode":5,"change":11.09,"latestTime":"05-07 16:00:00 EDT","open":768.9,"high":779.09,"low":762.11,"amount":2228690826.2212,"amplitude":0.022147,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":5.8,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1715155200000},"adr":0,"listingDate":102488400000,"adjPreClose":766.68,"adrRate":0,"dividendRate":0.00603,"preHourTrading":{"tag":"盘前","latestPrice":766.66,"preClose":766.68,"latestTime":"09:29 EDT","volume":3060,"amount":2341419.4044000003,"timestamp":1715088588811},"postHourTrading":{"tag":"盘后","latestPrice":777.26,"preClose":777.77,"latestTime":"19:59 EDT","volume":187635,"amount":145909315.1593,"timestamp":1715126353101},"volumeRatio":0.671482},"requestUrl":"/m/hq/s/LLY","defaultTab":"news","newsList":[{"id":"2433731788","title":"彭博根据13F报告汇编的数据显示，奥本海默一季度减持苹果，增持礼来制药","url":"https://stock-news.laohu8.com/highlight/detail?id=2433731788","media":"华尔街见闻","top":-1,"share":"https://www.laohu8.com/m/news/2433731788?lang=zh_cn&edition=full","pubTime":"2024-05-08 03:33","pubTimestamp":1715110434,"startTime":"0","endTime":"0","summary":"彭博根据13F报告汇编的数据显示，奥本海默（Oppenheimer & Co.）一季度减持 苹果 ，增持 礼来 制药。对电信股的增持权重超过对其他板块，新进SimilarWeb Ltd.和Spotify Technology SA等股票。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050803471787dd79e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050803471787dd79e5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433733531","title":"礼来上涨1.27%，报776.41美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2433733531","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2433733531?lang=zh_cn&edition=full","pubTime":"2024-05-08 01:19","pubTimestamp":1715102387,"startTime":"0","endTime":"0","summary":"5月8日，礼来(LLY)盘中上涨1.27%，截至01:19，报776.41美元/股，成交10.78亿美元。财务数据显示，截至2024年03月31日，礼来收入总额87.68亿美元，同比增长25.98%；归母净利润22.43亿美元，同比增长66.77%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/05/08011940555616.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433020364","title":"礼来上涨3.04%，报757.285美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2433020364","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2433020364?lang=zh_cn&edition=full","pubTime":"2024-05-07 00:51","pubTimestamp":1715014282,"startTime":"0","endTime":"0","summary":"5月7日，礼来(LLY)盘中上涨3.04%，截至00:51，报757.285美元/股，成交10.94亿美元。财务数据显示，截至2024年03月31日，礼来收入总额87.68亿美元，同比增长25.98%；归母净利润22.43亿美元，同比增长66.77%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/05/07005140537160.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433408613","title":"科学家称，拥有两个风险基因拷贝的人患有遗传形式的阿尔茨海默氏症","url":"https://stock-news.laohu8.com/highlight/detail?id=2433408613","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433408613?lang=zh_cn&edition=full","pubTime":"2024-05-06 23:00","pubTimestamp":1715007604,"startTime":"0","endTime":"0","summary":"三十年前，科学家们就已经知道，有两个 APOE4 基因变异拷贝的人患阿尔茨海默病的风险明显高于有最常见的 APOE 基因的人。大约 2% 到 3% 的普通人群或大约 15% 的阿尔茨海默氏症患者有两个 APOE4 基因变异拷贝。研究人员说，研究结果表明，APOE4 基因同源者符合遗传病的三个主要标准：几乎所有携带这两种基因变异的人都有阿尔茨海默氏症生物学特征；他们出现症状的速度大致相同；临床和生物学变化以可预测的顺序发生。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433341290","title":"AI引领医药革命：礼来首席信息官揭示生成式AI在药物发现中的惊人潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2433341290","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2433341290?lang=zh_cn&edition=full","pubTime":"2024-05-06 15:41","pubTimestamp":1714981264,"startTime":"0","endTime":"0","summary":"劳的分享不仅揭示了AI在医药领域的巨大潜力，也引发了行业内外对AI药物发现未来趋势的广泛关注。据从事AI和医疗保健交叉领域工作的高管透露，未来几年内，AI生产药物将成为药物发现的一种规范。这种数字化趋势为AI在药物发现中的应用提供了广阔的空间和无限的可能性。这些都是AI药物发现领域需要关注和解决的问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405061545428b7905f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405061545428b7905f1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433412970","title":"诺和诺德PK礼来，GLP-1王者之争谁能笑到最后？","url":"https://stock-news.laohu8.com/highlight/detail?id=2433412970","media":"21财经","top":-1,"share":"https://www.laohu8.com/m/news/2433412970?lang=zh_cn&edition=full","pubTime":"2024-05-06 15:36","pubTimestamp":1714980960,"startTime":"0","endTime":"0","summary":"近日，诺和诺德、礼来接连披露了2024年第一季度业绩。尽管此前有观点称美国国会正在施压诺和诺德，要求其降低Wegovy和Ozempic减肥药的价格，但两家药企对于GLP-1市场的前景仍报以乐观的态度。诺和诺德以55.3%的市场份额继续统领全球GLP-1类糖尿病市场。在诺和诺德GLP-1药物面临降价危机后，不少业内人士认为，礼来替尔泊肽的降价也势在必行。在此趋势之下，降价后的礼来、诺和诺德也需面对国产玩家的竞争，目前，多家国产GLP-1布局企业已经不断更新临床进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405061539427a583223&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405061539427a583223&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"1124858759","title":"虎氣生財 | 瑞銀料港股繼續上升！安進上週五飆12%，減肥藥領域該如何選股？巴菲特2024股東大會說了什麼？","url":"https://stock-news.laohu8.com/highlight/detail?id=1124858759","media":"老虎資訊HK","top":-1,"share":"https://www.laohu8.com/m/news/1124858759?lang=zh_cn&edition=full","pubTime":"2024-05-06 12:49","pubTimestamp":1714970946,"startTime":"0","endTime":"0","summary":"港股過去两周領跑環球市場，後市如何？巴菲特2024股东大会，十大要點回顧。本輪外資買入，是看中了什麼？自2023年以來，該公司的股票已經上漲了80%。布拉德韋在電話會議上表示，安進公司正計劃在肥胖癥、肥胖相關疾病和糖尿病方面進行後期研究。減肥藥領域，該如何選股？肥胖是一個不會消失的重大的健康問題，因此市場對於減肥藥的需求很大。投資者有理由看好減肥藥股票的前景。","market":"other","thumbnail":"https://community-static.tradeup.com/news/70b66bb113f54d2a2141949b33742a24","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/70b66bb113f54d2a2141949b33742a24"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"gpt_icon":1},{"id":"2433746163","title":"减肥药双雄再掀高潮，诺和诺德与礼来谁更漂亮？","url":"https://stock-news.laohu8.com/highlight/detail?id=2433746163","media":"蓝鲸财经","top":-1,"share":"https://www.laohu8.com/m/news/2433746163?lang=zh_cn&edition=full","pubTime":"2024-05-06 09:39","pubTimestamp":1714959577,"startTime":"0","endTime":"0","summary":"今年以来，英伟达和台积电股价分别累涨67.69%和30.26%，而礼来和诺和诺德的股价累计涨幅则分别达到33.25%和24.90%，其中礼来的往绩市盈率更比诺和诺德高出一倍有余，预期市盈率也高达57.86倍，或因市场对其2023年11月才获得美国上市批准的正规减肥药产品Zepbound强劲的销售增长寄予厚望。这或得益于减肥药Zepbound销量的强劲增长以及糖尿病用药Mounjaro已实现价格的提升，而诺和诺德的毛利率高达84.83%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/231411","is_publish_highlight":false,"gpt_icon":0},{"id":"2433856140","title":"礼来2024财年第一财季实现净利润22.43亿美元，同比增加66.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433856140","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433856140?lang=zh_cn&edition=full","pubTime":"2024-05-05 00:21","pubTimestamp":1714839684,"startTime":"0","endTime":"0","summary":"3月31日，礼来公布财报，公告显示公司2024财年第一财季净利润为22.43亿美元，同比增加66.77%；其中营业收入为87.68亿美元，同比增加25.98%，每股基本收益为2.49美元。机构评级：截至2024年3月31日，当前有25家机构对礼来目标价做出预测，其中目标均价为853.87美元，其中最低目标价为540.00美元，最高目标价为1023.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405050021318b73c282&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405050021318b73c282&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432151864","title":"隔夜美股全复盘(5.4)| 非农爆冷，三大股指集体收涨；苹果大涨6%，第二财季营收好于预期，宣布回购1100亿美元股票，苹果CEO库克据悉下周将预告新的AI功能","url":"https://stock-news.laohu8.com/highlight/detail?id=2432151864","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2432151864?lang=zh_cn&edition=full","pubTime":"2024-05-04 07:17","pubTimestamp":1714778226,"startTime":"0","endTime":"0","summary":"非农爆冷，三大股指集体收涨；苹果大涨6%，第二财季营收好于预期，宣布回购1100亿美元股票，苹果CEO库克据悉下周将预告新的AI功能","market":"sg","thumbnail":"https://img7.gelonghui.com/column/2/140.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/140.png"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/726253","is_publish_highlight":false,"gpt_icon":0},{"id":"2432690449","title":"礼来下跌3.02%，报733.08美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2432690449","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2432690449?lang=zh_cn&edition=full","pubTime":"2024-05-03 23:03","pubTimestamp":1714748602,"startTime":"0","endTime":"0","summary":"5月3日，礼来(LLY)盘中下跌3.02%，截至23:03，报733.08美元/股，成交11.79亿美元。财务数据显示，截至2024年03月31日，礼来收入总额87.68亿美元，同比增长25.98%；归母净利润22.43亿美元，同比增长66.77%。大事提醒：5月1日，礼来获蒙特利尔资本市场上调目标价至1001美元，最新评级Outperform。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/05/03230340516321.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"1133106210","title":"礼来跌3%，安进减肥新药中期试验获积极数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1133106210","media":"老虎资讯综合","top":-1,"share":"https://www.laohu8.com/m/news/1133106210?lang=zh_cn&edition=full","pubTime":"2024-05-03 22:38","pubTimestamp":1714747095,"startTime":"0","endTime":"0","summary":"如果该药物获得批准，它将与诺和诺德的Wegovy和礼来的Zepbound竞争。","market":"us","thumbnail":"https://static.tigerbbs.com/9e39bba9de237c79db4afa849623de3a","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/9e39bba9de237c79db4afa849623de3a"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"gpt_icon":0},{"id":"2432954927","title":"BUZZ-竞争对手安进公司对中期减肥药物数据表示 \"满意\"，维京下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2432954927","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432954927?lang=zh_cn&edition=full","pubTime":"2024-05-03 19:00","pubTimestamp":1714734027,"startTime":"0","endTime":"0","summary":"** 竞争对手安进  周四晚些时候表示， ，其实验性减肥药MariTide的中期研究的中期安全性和有效性数据令其 \"非常满意\"。** AMGN股价盘前上涨14.1%至317.65美元，该公司预计将在今年晚些时候公布MariTide的中期数据。** 在一项研究中，VKTX公司的注射减肥药平均帮助患者减轻了近15%的体重  ** 减肥药市场领军企业百合  盘前股价下跌2%，诺和诺德  下跌4%。** 截至上次收盘，VKTX 的股价今年已翻了两番多** 今年以来，AMGN下跌3.3%，LLY上涨约30%，诺和诺德上涨约20","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432728921","title":"竞争对手安进公司预告减肥药数据后，诺和诺德下跌 5","url":"https://stock-news.laohu8.com/highlight/detail?id=2432728921","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432728921?lang=zh_cn&edition=full","pubTime":"2024-05-03 18:24","pubTimestamp":1714731850,"startTime":"0","endTime":"0","summary":"截至格林尼治标准时间10时22分，诺和诺德股价下跌4.4%，当天早些时候曾创下两个月来的最低点。安进公司周四表示， ，在完成了实验性减肥药MariTide中期研究的中期分析后，该公司感到非常鼓舞。安进公司没有提供有关其试验实际数据的任何具体信息，但在这个估计到本世纪末价值将高达1000亿美元的市场上，竞争正日趋白热化，而诺和诺德公司目前在这一市场上处于领先地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432921104","title":"更新版 1-安进公司预告减肥药数据后股价大涨，竞争对手股价下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2432921104","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432921104?lang=zh_cn&edition=full","pubTime":"2024-05-03 18:16","pubTimestamp":1714731404,"startTime":"0","endTime":"0","summary":"不过，安进公司没有提供实际数据的具体细节，并表示计划在今年晚些时候启动一项后期研究。安进公司的评论在周五拉低了竞争对手的股价。礼来公司下跌了2.6%，诺和诺德公司在丹麦交易的股票下跌了近5%。作为蓝筹股道琼斯指数  的一部分，安进公司的股价在盘前交易中上涨了14.1%，达到317.65美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432792662","title":"BUZZ-安进公司称减肥药中期分析 \"令人鼓舞\"，股价大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2432792662","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432792662?lang=zh_cn&edition=full","pubTime":"2024-05-03 17:44","pubTimestamp":1714729472,"startTime":"0","endTime":"0","summary":"    5月3日 - ** 制药商安进  股价盘前上涨13.51%至316美元** 该公司周四晚些时候表示， ，在完成了对其实验性减肥药物MariTide的中期研究的中期分析后，它感到 \"非常鼓舞\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432925746","title":"安进公司预告 \"令人鼓舞 \"的减肥数据后股价大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2432925746","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432925746?lang=zh_cn&edition=full","pubTime":"2024-05-03 17:34","pubTimestamp":1714728840,"startTime":"0","endTime":"0","summary":"业绩公布后， 经纪公司加拿大皇家银行将安进公司的目标股价下调了 4 美元，降至 332 美元 。安进公司的股票是蓝筹股道琼斯指数  的一部分，在过去12个月里上涨了21%，但表现不如减肥市场的领先者礼来  和诺和诺德  ，后者分别上涨了约75%和54%。安进公司的股价是其 12 个月预期收益的 13.9 倍，而诺和诺德公司的远期市盈率为 34.2 倍，礼来公司为 48.49 倍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432948180","title":"诺和诺德提升Wegovy发货量，应对礼来的竞争对价格的压力","url":"https://stock-news.laohu8.com/highlight/detail?id=2432948180","media":"金十数据","top":-1,"share":"https://www.laohu8.com/m/news/2432948180?lang=zh_cn&edition=full","pubTime":"2024-05-03 14:21","pubTimestamp":1714717297,"startTime":"0","endTime":"0","summary":"诺和诺德减肥药Wegovy在美国市场首度大规模推出，销售额猛增，但价格竞争和供应问题仍是制约因素。诺和诺德的重磅减肥Wegovy在美国的首发剂量增加，目前该公司正努力应对供应紧张和来自礼来的竞争。对Wegovy及其治疗糖尿病的姊妹药Ozempic的需求促使该公司提高了预期，称今年的销售额可能会飙升27%，营业利润可能会增长30%。该药的标价为936美元，而Wegovy的标价为1349美元。随着患者逐渐增加对Wegovy的使用，该制药商将继续对使用低剂量Wegovy施加一些限制。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405031421398b6f85af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405031421398b6f85af&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432537670","title":"更新版 1-诺和诺德第一季度美国 Wegovy 和 Ozempic 价格下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2432537670","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432537670?lang=zh_cn&edition=full","pubTime":"2024-05-02 20:24","pubTimestamp":1714652688,"startTime":"0","endTime":"0","summary":"     路透伦敦5月2日 - 诺和诺德  的一位高管周四表示，由于销量和竞争加剧，该公司大受欢迎的减肥药Wegovy和糖尿病药物Ozempic 在美国的价格下降。关于 Ozempic，Knudsen 随后在投资者电话会议上表示，\"我们确实看到美国市场的价格在继续下降\"，他还提到了销量增加和竞争加剧的问题。Ozempic 含有与 Wegovy 相同的活性成分，但属于 2 型糖尿病治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432798586","title":"减肥药双雄再掀高潮，诺和诺德与礼来谁更漂亮？","url":"https://stock-news.laohu8.com/highlight/detail?id=2432798586","media":"财华社","top":-1,"share":"https://www.laohu8.com/m/news/2432798586?lang=zh_cn&edition=full","pubTime":"2024-05-02 19:17","pubTimestamp":1714648678,"startTime":"0","endTime":"0","summary":"科技与医疗两大领域，在近十年以及未来至少十年的资本市场中，将持续成为最受瞩目的主题。","market":"other","thumbnail":"https://images.finet.hk/photoLib/title/202405_1/ecc1ee11-2f96-474f-967d-d3dfbff92d1b.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202405_1/ecc1ee11-2f96-474f-967d-d3dfbff92d1b.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/66337666bde0b3446563a1a1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lilly.com","stockEarnings":[{"period":"1week","weight":0.04},{"period":"1month","weight":-0.0224},{"period":"3month","weight":0.0874},{"period":"6month","weight":0.2383},{"period":"1year","weight":0.7921},{"period":"ytd","weight":0.3152}],"compareEarnings":[{"period":"1week","weight":0.0128},{"period":"1month","weight":-0.0036},{"period":"3month","weight":0.0457},{"period":"6month","weight":0.1814},{"period":"1year","weight":0.2519},{"period":"ytd","weight":0.0868}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"礼来公司于1901年在印第安纳州注册成立，其前身是1876年由伊利·礼来上校在印第安纳州印第安纳波利斯创立的药品生产企业。公司发现，开发，制造和销售重要医药产品。公司的宗旨是将“关爱”与“发现”结合起来，为世界各地的人们创造更美好的生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.011498},{"month":2,"riseRate":0.5,"avgChangeRate":-0.002909},{"month":3,"riseRate":0.613636,"avgChangeRate":0.015389},{"month":4,"riseRate":0.555556,"avgChangeRate":0.018718},{"month":5,"riseRate":0.4,"avgChangeRate":0.013389},{"month":6,"riseRate":0.590909,"avgChangeRate":0.021126},{"month":7,"riseRate":0.568182,"avgChangeRate":0.002184},{"month":8,"riseRate":0.409091,"avgChangeRate":0.00001},{"month":9,"riseRate":0.454545,"avgChangeRate":0.003204},{"month":10,"riseRate":0.590909,"avgChangeRate":0.014439},{"month":11,"riseRate":0.75,"avgChangeRate":0.027866},{"month":12,"riseRate":0.590909,"avgChangeRate":0.031834}],"exchange":"NYSE","name":"礼来","nameEN":"Eli Lilly"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"礼来(LLY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供礼来(LLY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"礼来,LLY,礼来股票,礼来股票老虎,礼来股票老虎国际,礼来行情,礼来股票行情,礼来股价,礼来股市,礼来股票价格,礼来股票交易,礼来股票购买,礼来股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"礼来(LLY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供礼来(LLY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}